Open AccessA novel EGFR exon 21 indel mutation in lung adenocarcinoma and response to dacomitinib: A case report
Author(s) -
Tao Zhou,
Qing Xiong,
Hong Chen,
Qian Wang,
Wenxian Wang,
C. Xu,
Jing Cai
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000030269
Subject(s) - medicine , afatinib , lung cancer , adenocarcinoma , oncology , epidermal growth factor receptor , tyrosine kinase inhibitor , targeted therapy , gefitinib , cancer